Synera

ApprovedSmall molecule

ZZARS Pharma Inc.

Synera is one of 62 small molecule programs targeting Carpal Tunnel Syndrome. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Carpal Tunnel SyndromeActive, not recruiting

Shoulder Impingement SyndromeActive, not recruiting

EpicondylitisActive, not recruiting

OsteoarthritisActive, not recruiting

Carpal Tunnel SyndromePhase 2

Active, not recruiting

Shoulder Impingement SyndromePhase 2

Active, not recruiting

EpicondylitisApproved

Active, not recruiting

OsteoarthritisPhase 1/Phase 2

Active, not recruiting

Competition

Competitive Landscape

778 competitors in Osteoarthritis

#DrugCompanyPhaseTrials

Synera

ZZARS Pharma Inc.

Approved

1 2

Epidiolex

Jazz Pharmaceuticals

Preclinical

4 3

Ilaris

Novartis

Preclinical

2 4

Toradol

Roche

Preclinical

1 5

Cataflam

Bayer Aspirin

Voltaren

CCerimon Pharmaceuticals

Preclinical

4 8

Precedex

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Preclinical

1 9

Catapres

Boehringer Ingelheim

Preclinical

1 10

Paracetamol

GSK

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Osteoarthritis1 trial

Efficacy and Safety of Synera in Osteoarthritis Pain

Completed·—·Phase 1/2·NCT01654302·40 enrolled

Infiltration1 trial

Study of Use of Synera for Pain During Local Skin Infiltration With Lidocaine Before Epidural Placement

Withdrawn·NNorthwell Health·Phase 4·NCT01775605

Epidural1 trial

Synera™ for Epidural Needle Insertion

Completed·IIWK Health Centre·Phase 4·NCT00564785·33 enrolled

Pain1 trial

Synera Venipuncture Pain

Completed·UUS Oncology Research·Phase 2·NCT01744197·61 enrolled

Anesthesia1 trial

Evaluate the Depth and Duration of Anesthesia

Completed·ZZARS Pharma Inc.·Phase 4·NCT00891163·25 enrolled

5 more indications

Shoulder Impingement Syndrome1 trial

Pain Patch Versus Injections in the Treatment of Pain Associated With Shoulder Impingement Syndrome

Unknown status·IInjury Care Medical Center·Phase 2·NCT01544283·60 enrolled

Carpal Tunnel Syndrome1 trial

Open-Label Study Evaluating Synera® in the Treatment of Patients With Carpal Tunnel Syndrome

Completed·ZZARS Pharma Inc.·Phase 2·NCT00991068·24 enrolled

Children1 trial

Comparison of Synera Patch Versus LMX-4 Cream Versus Placebo Patch for Pain Reduction During Venipuncture in Children

Completed·CCarol Morreale·Phase 2·NCT01115062·150 enrolled

Epicondylitis1 trial

Study to Evaluate the Efficacy of the Synera Patch Compared to Naproxen Sodium for Epicondylitis of the Elbow

Completed·IInternational Clinical Research Institute·Phase 4·NCT01525043·78 enrolled

Unspecified1 trial

Pharmacokinetic Study of Synera in Healthy Volunteers

Completed·ZZARS Pharma Inc.·Phase 1·NCT01602757·12 enrolled

Sources

References

[1]
ClinicalTrials.gov — 10 trial records for Synera. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Synera compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Synera. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — ZARS Pharma Inc. company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: ZZARS Pharma Inc.

Synera

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Osteoarthritis1 trial

Infiltration1 trial

Epidural1 trial

Pain1 trial

Anesthesia1 trial

Shoulder Impingement Syndrome1 trial

Carpal Tunnel Syndrome1 trial

Children1 trial

Epicondylitis1 trial

Unspecified1 trial

References

Drug Info

Quick Facts

Related News